Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/04/2012WO2012135528A2 Galectin-3c combination therapy for human cancer
10/04/2012WO2012135498A2 Nutritional supplement comprising nut and seed oil composition
10/04/2012WO2012135465A2 Treatment of glaucoma
10/04/2012WO2012135402A1 Antiviral compounds
10/04/2012WO2012135338A1 Processes for preparing tofacitinib salts
10/04/2012WO2012135299A1 2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds
10/04/2012WO2012135296A2 Imidazolyl amide compounds and uses related thereto
10/04/2012WO2012135274A1 Prevention of infection
10/04/2012WO2012135230A2 Compositions and methods to modulate hair growth
10/04/2012WO2012135175A1 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
10/04/2012WO2012135166A1 (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
10/04/2012WO2012135160A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
10/04/2012WO2012135152A1 Compositions for inhibiting gene expression and uses thereof
10/04/2012WO2012135149A2 Small molecule modulators of sirt1 activity activate p53 and suppress tumor growth
10/04/2012WO2012135133A1 Lipoxygenase inhibitors
10/04/2012WO2012135113A2 Cyclopropylamines as lsd1 inhibitors
10/04/2012WO2012135112A2 Methods for preparing deuterated 1,2,3-triazoles
10/04/2012WO2012135097A1 Methods of targeted treatment of frontotemporal lobar degeneration
10/04/2012WO2012135082A1 Prodrugs of lxr modulating imidazole derivatives
10/04/2012WO2012135081A2 Lin28-mediated control of let-7 biogenesis
10/04/2012WO2012135064A2 Attenuated strains of plasmodium
10/04/2012WO2012135049A1 Compounds and methods for chemical and chemo-enzymatic synthesis of complex glycans
10/04/2012WO2012135047A2 Methods and compositions for preparing noribogaine from voacangine
10/04/2012WO2012135027A2 Thiolactone antibiotics
10/04/2012WO2012135016A2 Inhibition of bacterial biofilms and microbial growth with imidazole derivatives
10/04/2012WO2012135010A2 Osmotic mediated release synthetic nanocarriers
10/04/2012WO2012134971A2 Opsin-binding ligands, compositions and methods of use
10/04/2012WO2012134965A1 Chloride channel and chloride transporter modulators for therapy in smooth muscle diseases
10/04/2012WO2012134943A1 Trpv1 antagonists
10/04/2012WO2012134828A1 Methods for treating heartburn and/or preventing gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
10/04/2012WO2012134606A1 Non-magnetic noble alloy containing ruthenium, cobalt and chromium
10/04/2012WO2012134590A2 Calcium supplement
10/04/2012WO2012134520A2 Regulation of immune response by colocynthin and/or its derivatives
10/04/2012WO2012134478A1 Compositions and methods for the treatment and prevention of cardiac ischemic injury
10/04/2012WO2012134446A1 Epiandrosterone and/or androsterone derivatives and method of use thereof
10/04/2012WO2012134445A1 An improved process for the preparation of paliperidone
10/04/2012WO2012134410A1 Compositions of opioid antagonists and their use for treating scleroderma
10/04/2012WO2012134392A1 Process for the production of a pemetrexed salt
10/04/2012WO2012134380A1 Pouch containing nicotine in free salt form
10/04/2012WO2012134351A1 Clathrate complexes of beta-cyclodextrin and 5-hydroxy-4-aminomethyl-1-cyclohexyl (or cycloheptyl)-3-alkoxycarbonyl indole derivative, which exhibit an anti-viral effect, and methods for producing said complexes
10/04/2012WO2012134258A1 Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
10/04/2012WO2012134234A2 Use of hades as a negative modulator of akt
10/04/2012WO2012134233A2 Sulphamide derivative having an adamantyl group and a pharmaceutically acceptable salt thereof
10/04/2012WO2012134231A2 Benzamide derivative as cannabinoid receptor (cb1) antagonist
10/04/2012WO2012134206A2 Process for the preparation of anhydrous aripiprazole crystal form ii
10/04/2012WO2012134188A2 Novel oxazolidinone derivative and medical composition containing same
10/04/2012WO2012134187A2 Pharmaceutical composition for preventing or treating macular degeneration
10/04/2012WO2012134184A2 Novel cephalosporin derivative and medical composition containing same
10/04/2012WO2012134172A2 Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity
10/04/2012WO2012134135A2 Spermine copolymer and gene therapy using the spermine copolymer as a nucleic-acid carrier
10/04/2012WO2012134126A2 Use of compounds isolated from morus bark
10/04/2012WO2012133997A1 Polysorbitol-based osmotically active transporter and gene therapy using same
10/04/2012WO2012133960A1 Inhibitor for dipeptidyl peptidase iv
10/04/2012WO2012133918A1 Solid preparation
10/04/2012WO2012133896A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012WO2012133884A1 Pharmaceutical composition containing block copolymer comprising boric acid compound
10/04/2012WO2012133802A1 Novel furanone derivative
10/04/2012WO2012133733A1 Cancer cell proliferation inhibitor
10/04/2012WO2012133693A1 Pharmaceutical combination for diabetes treatment
10/04/2012WO2012133648A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect
10/04/2012WO2012133607A1 Pyrazole compound
10/04/2012WO2012133554A1 Fat emulsion containing prostaglandin
10/04/2012WO2012133509A1 Novel benzimidazole derivative
10/04/2012WO2012133492A1 Ointment with excellent formulation stability
10/04/2012WO2012133489A1 Pharmaceutical composition for treatment or prophylaxis of neurogenic diseases
10/04/2012WO2012133416A1 Method for producing phenoxypyridine derivative
10/04/2012WO2012133198A1 Nutritional composition for inflammatory diseases
10/04/2012WO2012133121A1 Long-lasting controlled-release liposome composition and method for producing same
10/04/2012WO2012133005A1 Fat-reducing agent
10/04/2012WO2012132913A1 Clostridium difficile growth inhibitor
10/04/2012WO2012132747A1 Liquid composition for oral cavity and method for stable addition of components to composition
10/04/2012WO2012132067A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012WO2012132022A1 Agent for promoting gene transfer and method of gene transfer using the same
10/04/2012WO2012131734A1 Topical composition for the treatment of vitiligo
10/04/2012WO2012131722A1 Controlled release composition of betahistine
10/04/2012WO2012131706A1 Amorphous form of vilazodone hydrochloride and process for its preparation
10/04/2012WO2012131698A1 Process for preparing docetaxel and its hydrate
10/04/2012WO2012131690A1 Drug delivery form as a bilayer tablet
10/04/2012WO2012131689A1 Insulin mimetic active comprising oxodiperoxo vanadates and a pharamaceutical composition obtained thereof
10/04/2012WO2012131678A1 Sustained-release injectable formulation
10/04/2012WO2012131669A1 Film-forming composition for a ph-dependant sustained release of the active agent
10/04/2012WO2012131656A2 Compounds for use as therapeutic agents affecting p53 expression and/or activity
10/04/2012WO2012131638A1 Functional food for male use including muirapuamine and yohimbine
10/04/2012WO2012131633A1 Pyrazolo pyrimidine derivatives
10/04/2012WO2012131629A1 A process for preparation of intermediate of moxifloxacin
10/04/2012WO2012131588A1 3-ureidoisoquinolin-8-yl derivatives
10/04/2012WO2012131576A1 Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease
10/04/2012WO2012131539A1 Novel bicyclic pyridinones
10/04/2012WO2012131501A1 Substituted benzimidazole compounds as cot kinase inhibitors
10/04/2012WO2012131493A1 Compositions for the treatment of neurologic disorders
10/04/2012WO2012131487A2 Compositions and methods for the treatment of cancer
10/04/2012WO2012131468A1 Crystalline forms of fused amino pyridines as hsp90 inhibitors
10/04/2012WO2012131413A1 Crystalline forms of fused amino pyridines as hsp90 inhibitors
10/04/2012WO2012131412A2 Pharmaceutical composition containing no, process for the preparation and use thereof
10/04/2012WO2012131399A1 Therapeutic treatment
10/04/2012WO2012131396A1 3 -descladinosyl-o- carbamoyl functionalized derivatives of azithromycin
10/04/2012WO2012131389A1 Process for the preparation of 1 - ( 2 -methyl - 4 - ( 2, 3, 4, 5 - tetrahydro - 1 - benzazepin- 1 -ylcarbonyl) benzylcarbamoyl) - l - proline - n, n- dimethylamide
10/04/2012WO2012131379A1 Thieno [2, 3 -d] pyrimidine derivatives and their use to treat arrhythmia
10/04/2012WO2012131365A1 Therapeutic molecules for use in the suppression of parkinson's disease
10/04/2012WO2012131348A1 Salicylic acid topical formulation
1 ... 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 ... 7860